Currently, there are 1.28B common shares owned by the public and among those 1.28B shares have been available to trade.
The company’s stock has a 5-day price change of 1.72% and 3.50% over the past three months. LRCX shares are trading 12.21% year to date (YTD), with the 12-month market performance down to -3.03% lower. It has a 12-month low price of $68.87 and touched a high of $113.00 over the same period. LRCX has an average intraday trading volume of 11.71 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.40%, 7.10%, and -4.36% respectively.
Institutional ownership of Lam Research Corp (NASDAQ: LRCX) shares accounts for 77.64% of the company’s 1.28B shares outstanding.
It has a market capitalization of $104.29B and a beta (3y monthly) value of 1.47. The stock’s trailing 12-month PE ratio is 24.63, while the earnings-per-share (ttm) stands at $3.29. The company has a PEG of 1.57 and a Quick Ratio of 1.73 with the debt-to-equity ratio at 0.57. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.30% over the week and 3.36% over the month.
Analysts forecast that Lam Research Corp (LRCX) will achieve an EPS of 1.0 for the current quarter, 0.98 for the next quarter and 3.94 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.86 while analysts give the company a high EPS estimate of 0.86. Comparatively, EPS for the current quarter was 0.78 a year ago. Earnings per share for the fiscal year are expected to increase by 23.47%, and 4.01% over the next financial year. EPS should shrink at an annualized rate of 15.68% over the next five years, compared to 16.17% over the past 5-year period.
Looking at the support for the LRCX, a number of firms have released research notes about the stock. Cantor Fitzgerald stated their Overweight rating for the stock in a research note on January 30, 2025, with the firm’s price target at $100. Bernstein coverage for the Lam Research Corp (LRCX) stock in a research note released on January 30, 2025 offered a Outperform rating with a price target of $91. Cleveland Research on their part issued Neutral rating on December 17, 2024.
